openPR Logo
Press release

Global Dermatological Products Market Revenue Growth Predicted by 2018 to 2028 | Key Players are Ikeda Mohando Co Ltd., Johnson & Johnson Consumer Ltd., Taisho Pharmaceutical, etc.

05-20-2019 08:30 AM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Global Dermatological Products Market Revenue Growth

FactMR has actively published a new research study titled “Global Dermatological Products Market Revenue Growth Predicted by 2018 to 2028 | Key Players are Ikeda Mohando Co Ltd., Johnson & Johnson Consumer Ltd., Taisho Pharmaceutical, etc.” to its broad online database. This assessment works to discourse the major trends, opportunities and drivers motivating the dermatological products market during the period from 2018-2028. The insights structured for presenting the target market are procured from both primary research and secondary research, and are utilized for validation that is valuable to investors, manufacturers and new entrants. As per research findings, the global dermatological products market is expected to showcase impressive growth at 3.7% CAGR during the period until 2028.

Request a Free Sample Report from Here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2363

Biologic agents or protein-based drugs are increasingly used in dermatology for treatment of psoriasis. These products have also gained traction in the treatment of other inflammatory skin diseases. Treatment of psoriasis is the largest area of development for dermatological biologics. There are around 10 approved biologics in the dermatological products market to treat moderate to severe psoriasis. With advancement in biomedical science, manufacturers in dermatological products market are using new technologies such as bioinformatics, biomarkers, nanotechnology, and molecular targeting for medicine discovery. Production of biosimilars is likely to increase in dermatological products market as these drugs have similar active ingredients to biologic medicines and are more cost-effective.

Based on the regulatory approach of biosimilars, increasing number of biosimilar drugs are set to enter Europe and the US in the coming years. Moreover, with increasing prevalence of psoriasis in children across the world, manufacturers in dermatological products market are working towards developing effective biologics for children with psoriasis. The rise in skin allergies and lifestyle-related skin complaints is resulting in increasing use of dermo-cosmetic products by consumers to treat common skin conditions such as eczema, acne, extreme skin sensitivity, and reactive skin. Majority of the dermo-cosmetics products are developed on a large scale in Western European countries including Italy, France, and Spain.

New dermatological products formulas and developments are also on a rise, for instance, Pierre Fabre has launched sterile cosmetics, industries first sterile skincare line made without preservatives and fragrance. The company used a limited number of ingredients and offers D.E.F.I. (Device for Exclusive Formula Integrity) packaging. The packaging helps to protect formula from oxidation. In order to gain customer interest, brands in the dermatological products market are working with dermatologists to develop the formulation and also attach dermatologist-recommended claim. Dermatologists recommended brands are witnessing a rise in demand due to consumer belief that these dermatological products are safe and effective.

Browse Dermatological Products Market Report Here - https://www.factmr.com/report/2363/dermatological-products-market

Skin diseases constitute a major health problem among children worldwide. Most common skin conditions found in children are skin rashes, diaper dermatitis, atopic dermatitis, acne, and warts. According to the American Academy of Dermatology, nearly 25% of children compared to 2-3% of adults are affected by atopic dermatitis. Hence, manufacturers in dermatological products market are developing over-the-counter medications, as most of the skin problems in children are treatable with these medications.

Eczema is also emerging as a common skin problem among children due to the rise in viruses, bacteria, and fungi. Moisturizers treating eczema are being developed on a large scale. Moreover, diaper rash is the most common problem among babies. This is driving the demand for dermatological products including medicated creams and moisturizers especially developed to treat diaper rash. Dermatological products manufacturers are also focusing on developing a range of dermatological products that can be used by both children and adults. This can lead to cost-saving for consumers as well as manufacturers. However, the entire focus is on a formulation that should be safe to be used by adults and children at the same time.

According to the American Institute of Cancer Research, Melanoma is the 15th most commonly occurring cancer worldwide, nearly 300,000 new cases were registered in 2018. Australia, New Zealand, Norway, Denmark, and the Netherlands accounted for the highest rate of melanoma in 2018. Meanwhile, Melanoma International Foundation states that incidence is rising steadily globally, with one person dying each hour from melanoma.

With the rise in melanoma cases worldwide, the demand for dermatological products including sunscreen and creams have increased. Manufacturers in dermatological products market are also focusing on developing sunscreen products with SPF between 15 and 50 to provide better protection against damaging UV radiation.

Have Any Question? Ask Our Industry Experts - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2363

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dermatological Products Market Revenue Growth Predicted by 2018 to 2028 | Key Players are Ikeda Mohando Co Ltd., Johnson & Johnson Consumer Ltd., Taisho Pharmaceutical, etc. here

News-ID: 1744716 • Views:

More Releases from Fact.MR

Scara Robot Market Anticipated Growth to CAGR of 12.1% Towards US$ 19.2 Billion by 2033
Scara Robot Market Anticipated Growth to CAGR of 12.1% Towards US$ 19.2 Billion …
The worldwide Scara robotic market (スカラロボット市場) is anticipated to get to a worth of United States $ 6.1 billion by 2023 as well as is forecasted to expand at an intensifying yearly development price (CAGR) of 12.1% to get to United States $ 19.2 billion by the end of 2033. The Scara (Selective Compliance Articulated Robot Arm) robotic market has actually been experiencing durable development in the last few years sustained
Bioresorbable Polymers Market Growth at 15.8% CAGR by 2032
Bioresorbable Polymers Market Growth at 15.8% CAGR by 2032
The bioresorbable polymers market (生体吸収性ポリマー市場) deserved US$ 1.3 billion in 2021 and also is anticipated to get to United States$ 6.2 billion by 2032, with a predicted substance yearly development price (CAGR) of 15.8% from 2022 to 2032. Bioresorbable polymers likewise called naturally degradable polymers are obtaining considerable grip in biomedical applications because of their one-of-a-kind capacity to break down within the body in time. These polymers remove the requirement for
Carbon Dioxide Incubators Market to Reach $483.5 Million by 2027, with 8.4% CAGR
03-29-2024 | Health & Medicine
Fact.MR
Carbon Dioxide Incubators Market to Reach $483.5 Million by 2027, with 8.4% CAGR
The international carbon dioxide incubators market is predicted to expand at a CAGR of 8.4% over the following 5 years, with sales anticipated to raise from United States$ 323 million in 2022 to United States$ 483.5 million by 2027. Carbon dioxide incubators are important tools made use of in research study labs, professional setups and also biotechnology markets for cell society applications. These incubators develop a regulated setting with controlled temperature
Vegan Flavors Market Is Slated To Reach US$ 18,324.3 Million At A CAGR Of 5.2% B …
The global vegan flavor market is estimated to be valued at US$ 11,078.2 million in 2024 and is forecast to reach a value of US$ 18,324.3 million by 2034, with a projected CAGR of 5.2% from 2024 to 2034 owing to the rising popularity of plant-based diets. The Vegan Flavor Industry sales study offers a comprehensive analysis on diverse features including production capacities, Vegan Flavor demand, product developments, sales revenue generation

All 5 Releases


More Releases for Dermatological

Dermatological Drugs Market : Competitive Dynamics & Global Outlook 2031
Dermatological drugs Market - Overview The growth opportunities in the dermatological drugs market are growing at a noticeable speed due to numerous factors. Amongst these key factors, are the fungus, parasites, and some other microorganisms that are living on the skin. The bacteria are generally trapped in hair follicles and skin pores hold numerous fluids and prevent dehydration. These factors are estimated to fuel novel revenue generation opportunities in the market
Dermatological Drugs Market 2021: Global Industry Analysis Report to 2027
The global dermatological drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various diseases related to skin, nails, and hair, such as pigmentation, acne, wrinkles, and psoriasis. Dermatological agents, also known as dermatological, are products that are applied topically on the skin. These products are used to treat
Dermatological Drugs Market Report 2021-2031 - newly published
This new report will cover these areas: Forecasts by Disease (Psoriasis, Dermatitis, Acne, Skin Infections, Other Diseases), by Skin Infections Drugs (Bepanthen/Bepanthol, Protopic, Dermovate), by Psoriasis Drugs (Humira, Stelara, Enbrel, Remicade, Taltz, Otezla), by Dermatitis Drugs (Cubicin, Zyvox, Valtrex, Canesten, Lamisil, Other Dermatitis Drugs), by Route of Administration (Topical, Oral, Parenteral Administration) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Dermatological Drugs Companies AND COVID-19 Recovery Scenarios. What
Newly Released Visiongain Report: Dermatological Drugs Market Forecast 2020-2030
Psoriasis, Skin Infection, Acne, Dermatitis, Others To find out more about this report, click the link: https://www.visiongain.com/report/dermatological-drugs-market-forecast-2020-2030/ The revenue of the dermatological drugs market in 2018 is estimated at $31bn and is expected to grow at a CAGR of 3.7% in the first half of the forecast period. Psoriasis drugs segment accounted for the largest share of the market in 2018, this segment accounted for 38% of the global dermatological drugs market. How this
Dermatological Disorders Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Dermatological Disorders Medications market. Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-dermatological-disorders-medications-market_p103576.html Global Dermatological Disorders Medications Market: Forecast by Type / Application / Region The worldwide market for Dermatological Disorders Medications is
Global Dermatological Devices Market
The Global Dermatological Devices Market was valued at US$ 6,565.5 million in 2015 and is projected to expand at a CAGR of 7.6% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Rise in number of patients suffering from non-melanoma and melanoma skin cancers is expected to be one of the major factor to drive the dermatology devices market in the near future. According to